Global POC Hematology Diagnostics Market 2022-2026

Global POC Hematology Diagnostics Market 2022-2026

Technavio has been monitoring the POC hematology diagnostics market and it is poised to grow by $ 1.46 bn during 2022-2026, accelerating at a CAGR of 9.06% during the forecast period. Our report on the POC hematology diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of blood disorders and infectious diseases, increasing growth in product launches, and the paradigm shift from benchtop to portable hematology diagnostic systems.

The POC hematology diagnostics market analysis includes product segment and geographic landscape.

Technavio's POC hematology diagnostics market is segmented as below:

By Product

• Consumables
• Systems

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increase in online marketing as one of the prime reasons driving the poc hematology diagnostics market growth during the next few years. Also, increase in number of OEMs and increase in adoption of next-generation hematology diagnostic products will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on POC hematology diagnostics market covers the following areas:

• POC hematology diagnostics market sizing
• POC hematology diagnostics market forecast
• POC hematology diagnostics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading POC hematology diagnostics market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, Danaher Corp., DIAGON Kft., Drucker Diagnostics LLC, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., HORIBA Ltd., Medsource Ozone Biomedicals Pvt. Ltd., Nihon Kohden Corp., Norma Instruments Zrt., Nova Biomedical Corp., PixCell Medical Technologies Ltd., S.D. Sight Diagnostics Ltd., Sekisui Diagnostics LLC, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens AG, Sysmex Corp., Transasia Bio Medicals Ltd., and Werfenlife SA. Also, the POC hematology diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.